FDA label
What is Xiidra used for?
Xiidra contains lifitegrast. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Xiidra ®(lifitegrast ophthalmic solution) 5% is indicated for the treatment of the signs and symptoms of dry eye disease (DED).”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Xiidra?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Xiidra, solution/ drops
Indications and Usage, quoted from the label by Novartis Pharmaceuticals Corporation (NDA208073). Cross-references to other label sections are left out.
Xiidra ®(lifitegrast ophthalmic solution) 5% is indicated for the treatment of the signs and symptoms of dry eye disease (DED).
Source: DailyMed label, set id 8589d376-ac10-4ddb-9c53-2e0c8d5675c4, version 6, effective August 18, 2025. NDC 0078-0911, one of 2 listings for this product.
Questions
What is Xiidra used for?
The FDA label says: “Xiidra ®(lifitegrast ophthalmic solution) 5% is indicated for the treatment of the signs and symptoms of dry eye disease (DED).”
What drug class is Xiidra?
FDA lists lifitegrast in the Lymphocyte Function-Associated Antigen-1 Antagonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.